These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16407771)

  • 1. Distribution of AAV2-hAADC-transduced cells after 3 years in Parkinsonian monkeys.
    Daadi MM; Pivirotto P; Bringas J; Cunningham J; Forsayeth J; Eberling J; Bankiewicz KS
    Neuroreport; 2006 Feb; 17(2):201-4. PubMed ID: 16407771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbidopa-based modulation of the functional effect of the AAV2-hAADC gene therapy in 6-OHDA lesioned rats.
    Ciesielska A; Sharma N; Beyer J; Forsayeth J; Bankiewicz K
    PLoS One; 2015; 10(4):e0122708. PubMed ID: 25860990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial.
    Ciesielska A; Samaranch L; San Sebastian W; Dickson DW; Goldman S; Forsayeth J; Bankiewicz KS
    PLoS One; 2017; 12(2):e0169965. PubMed ID: 28166239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2-hAADC.
    Hadaczek P; Eberling JL; Pivirotto P; Bringas J; Forsayeth J; Bankiewicz KS
    Mol Ther; 2010 Aug; 18(8):1458-61. PubMed ID: 20531394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach.
    Bankiewicz KS; Eberling JL; Kohutnicka M; Jagust W; Pivirotto P; Bringas J; Cunningham J; Budinger TF; Harvey-White J
    Exp Neurol; 2000 Jul; 164(1):2-14. PubMed ID: 10877910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats.
    Sánchez-Pernaute R; Harvey-White J; Cunningham J; Bankiewicz KS
    Mol Ther; 2001 Oct; 4(4):324-30. PubMed ID: 11592835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes.
    Muramatsu S; Fujimoto K; Ikeguchi K; Shizuma N; Kawasaki K; Ono F; Shen Y; Wang L; Mizukami H; Kume A; Matsumura M; Nagatsu I; Urano F; Ichinose H; Nagatsu T; Terao K; Nakano I; Ozawa K
    Hum Gene Ther; 2002 Feb; 13(3):345-54. PubMed ID: 11860702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution of adeno-associated virus type-2 in nonhuman primates after convection-enhanced delivery to brain.
    Cunningham J; Pivirotto P; Bringas J; Suzuki B; Vijay S; Sanftner L; Kitamura M; Chan C; Bankiewicz KS
    Mol Ther; 2008 Jul; 16(7):1267-75. PubMed ID: 18523450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum.
    San Sebastian W; Richardson RM; Kells AP; Lamarre C; Bringas J; Pivirotto P; Salegio EA; Dearmond SJ; Forsayeth J; Bankiewicz KS
    Hum Gene Ther; 2012 Feb; 23(2):210-7. PubMed ID: 22017504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC.
    Bankiewicz KS; Forsayeth J; Eberling JL; Sanchez-Pernaute R; Pivirotto P; Bringas J; Herscovitch P; Carson RE; Eckelman W; Reutter B; Cunningham J
    Mol Ther; 2006 Oct; 14(4):564-70. PubMed ID: 16829205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons.
    Pearson TS; Gupta N; San Sebastian W; Imamura-Ching J; Viehoever A; Grijalvo-Perez A; Fay AJ; Seth N; Lundy SM; Seo Y; Pampaloni M; Hyland K; Smith E; de Oliveira Barbosa G; Heathcock JC; Minnema A; Lonser R; Elder JB; Leonard J; Larson P; Bankiewicz KS
    Nat Commun; 2021 Jul; 12(1):4251. PubMed ID: 34253733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dose-ranging study of AAV-hAADC therapy in Parkinsonian monkeys.
    Forsayeth JR; Eberling JL; Sanftner LM; Zhen Z; Pivirotto P; Bringas J; Cunningham J; Bankiewicz KS
    Mol Ther; 2006 Oct; 14(4):571-7. PubMed ID: 16781894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parameters.
    Sanftner LM; Sommer JM; Suzuki BM; Smith PH; Vijay S; Vargas JA; Forsayeth JR; Cunningham J; Bankiewicz KS; Kao H; Bernal J; Pierce GF; Johnson KW
    Exp Neurol; 2005 Aug; 194(2):476-83. PubMed ID: 16022872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-associated virus-mediated gene transfer of human aromatic L-amino acid decarboxylase protects mixed striatal primary cultures from L-DOPA toxicity.
    Doroudchi MM; Liauw J; Heaton K; Zhen Z; Forsayeth JR
    J Neurochem; 2005 May; 93(3):634-40. PubMed ID: 15836622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain.
    Hadaczek P; Kohutnicka M; Krauze MT; Bringas J; Pivirotto P; Cunningham J; Bankiewicz K
    Hum Gene Ther; 2006 Mar; 17(3):291-302. PubMed ID: 16544978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent Expression of Dopamine-Synthesizing Enzymes 15 Years After Gene Transfer in a Primate Model of Parkinson's Disease.
    Sehara Y; Fujimoto KI; Ikeguchi K; Katakai Y; Ono F; Takino N; Ito M; Ozawa K; Muramatsu SI
    Hum Gene Ther Clin Dev; 2017 Jun; 28(2):74-79. PubMed ID: 28279081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimerizer regulation of AADC expression and behavioral response in AAV-transduced 6-OHDA lesioned rats.
    Sanftner LM; Rivera VM; Suzuki BM; Feng L; Berk L; Zhou S; Forsayeth JR; Clackson T; Cunningham J
    Mol Ther; 2006 Jan; 13(1):167-74. PubMed ID: 16126007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time MR imaging of adeno-associated viral vector delivery to the primate brain.
    Fiandaca MS; Varenika V; Eberling J; McKnight T; Bringas J; Pivirotto P; Beyer J; Hadaczek P; Bowers W; Park J; Federoff H; Forsayeth J; Bankiewicz KS
    Neuroimage; 2009 Aug; 47 Suppl 2(Suppl 2):T27-35. PubMed ID: 19095069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative imaging of adeno-associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease.
    Valles F; Fiandaca MS; Eberling JL; Starr PA; Larson PS; Christine CW; Forsayeth J; Richardson RM; Su X; Aminoff MJ; Bankiewicz KS
    Neurosurgery; 2010 Nov; 67(5):1377-85. PubMed ID: 20871425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys.
    Bankiewicz KS; Daadi M; Pivirotto P; Bringas J; Sanftner L; Cunningham J; Forsayeth JR; Eberling JL
    Exp Neurol; 2006 Feb; 197(2):363-72. PubMed ID: 16337943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.